Soleus Capital Master Fund L.P. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-04-23
9:45 pm
Unchanged
2025-04-2313DESSA PHARMA INC
EPIX
Soleus Capital Master Fund L.P.2,262,026
5.100%
0
(Unchanged)
Filing
History
2025-04-16
5:37 pm
Purchase
2025-04-1513GMURAL ONCOLOGY PUB LTD CO
MURA
Soleus Capital Master Fund L.P.1,079,927
6.300%
1,079,927increase
(New Position)
Filing
History
2025-04-15
4:46 pm
Purchase
2025-04-1513DESSA PHARMA INC
EPIX
Soleus Capital Master Fund L.P.2,262,026
5.100%
2,262,026increase
(New Position)
Filing
History
2025-04-11
7:30 pm
Sale
2025-04-1113DTHERATECHNOLOGIES INC
THTX
Soleus Capital Master Fund L.P.4,801,375
10.400%
-387,501decrease
(-7.47%)
Filing
History
2025-04-01
5:00 pm
Purchase
2025-03-3113GNOVOCURE LTD
NVCR
Soleus Capital Master Fund L.P.5,521,414
5.000%
5,521,414increase
(New Position)
Filing
History
2025-03-28
5:09 pm
Purchase
2025-03-2613GSTAAR SURGICAL CO
STAA
Soleus Capital Master Fund L.P.2,562,893
5.200%
2,562,893increase
(New Position)
Filing
History
2025-03-19
5:00 pm
Purchase
2025-03-1813GPRAXIS PRECISION MEDICINES INC
PRAX
Soleus Capital Master Fund L.P.1,017,740
5.000%
1,017,740increase
(New Position)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GRIGEL PHARMACEUTICALS INC
RIGL
Soleus Capital Master Fund L.P.1,130,679
6.400%
195,891increase
(+20.96%)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GORGANOGENESIS HLDGS INC CLASS
ORGO
Soleus Capital Master Fund L.P.12,484,876
9.900%
645,000increase
(+5.45%)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GJASPER THERAPEUTICS INC NE
JSPR
Soleus Capital Master Fund L.P.1,494,420
9.960%
507,324increase
(+51.40%)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GCELCUITY INC
CELC
Soleus Capital Master Fund L.P.3,872,184
9.900%
1,248,294increase
(+47.57%)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GTERNS PHARMACEUTICALS INC
TERN
Soleus Capital Master Fund L.P.8,142,500
9.600%
1,918,956increase
(+30.83%)
Filing
History
2025-02-11
4:00 pm
Purchase
2024-12-3113GVERASTEM INC
VSTM
Soleus Capital Master Fund L.P.3,350,692
7.300%
1,925,058increase
(+135.03%)
Filing
History
2025-01-22
5:15 pm
Purchase
2025-01-2113GSURMODICS INC
SRDX
Soleus Capital Master Fund L.P.739,060
5.200%
101,362increase
(+15.89%)
Filing
History
2024-11-14
3:36 pm
Sale
2024-09-3013GSURMODICS INC
SRDX
Soleus Capital Master Fund L.P.637,698
4.500%
-134,002decrease
(-17.36%)
Filing
History
2024-11-14
3:35 pm
Purchase
2024-09-3013GORGANOGENESIS HLDGS INC CLASS
ORGO
Soleus Capital Master Fund L.P.11,839,876
8.900%
2,876,876increase
(+32.10%)
Filing
History
2024-11-14
3:35 pm
Sale
2024-09-3013GIRADIMED CORP COM
IRMD
Soleus Capital Master Fund L.P.1,000
0.000%
-642,206decrease
(-99.84%)
Filing
History
2024-11-14
3:34 pm
Sale
2024-09-3013GVYNE THERAPEUTICS INC PAR$
VYNE
Soleus Capital Master Fund L.P.0
0.000%
-14,077decrease
(Position Closed)
Filing
History
2024-11-14
3:33 pm
Sale
2024-09-3013GRIGEL PHARMACEUTICALS INC
RIGL
Soleus Capital Master Fund L.P.934,788
5.300%
-9,470decrease
(-1.00%)
Filing
History
2024-11-14
3:31 pm
Purchase
2024-09-3013GAXOGEN, INC.
AXGN
Soleus Capital Master Fund L.P.3,005,943
6.800%
410,128increase
(+15.80%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, Next